Current CTU Trials
We work with clinical academics across the Kent, Surrey and Sussex region to design, coordinate, manage and disseminate UK and Europe-wide multi-centre, interventional clinical trials.
We support multi-centre trials (Phase I – III) including those in Oncology, palliative care, vaccine development, hepatology and diabetes.
|Study code||Title||Disease||Recruitment||Study Start (expected)||Status||More information|
|CTU-331||eSMART: Randomised controlled trial to evaluate electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology for patients with cancers||Device Trial in Breast, Colorectal and Haematological Cancer||Open||September 2015||Click here|
|CTU-340||CHELsea: Clinically Assisted Hydration at end of Life. A cluster randomised trial of clinically-assisted hydration for cancer patients in the last days of life (feasibility study)||Cancer||Closed||February 2015||Analysis & Reporting||Click here|
|CTU-368||EDMONd: A feasibility study of Elemental Diet as an alternative to parenteral nutrition for ovarian cancer patients with inoperable Malignant bowel Obstruction||Ovarian Cancer||Open||June 2017||Click here|
|CTU-376||RosProx: Preventing muscle wasting in critically ill patients by repetitive occlusive stimulus (ROS): a feasibility study||Critical Care (ICU)||Open||September 2017||Click here|